Literature DB >> 17329634

Methodology matters.

Lainie Friedman Ross.   

Abstract

Mesh：

Year:  2007        PMID： 17329634      PMCID： PMC1829341          DOI： 10.2105/AJPH.2006.107169

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  3 in total

1.  Combining immunoreactive trypsinogen and pancreatitis-associated protein assays, a method of newborn screening for cystic fibrosis that avoids DNA analysis.

Authors:  Jacques Sarles; Patrice Berthézène; Christian Le Louarn; Claude Somma; Jean-Marc Perini; Michael Catheline; Sophie Mirallié; Karine Luzet; Michael Roussey; Jean-Pierre Farriaux; Jacques Berthelot; Jean-Charles Dagorn
Journal:  J Pediatr       Date:  2005-09       Impact factor: 4.406

2.  Newborn screening: complexities in universal genetic testing.

Authors:  Nancy S Green; Siobhan M Dolan; Thomas H Murray
Journal:  Am J Public Health       Date:  2006-03-29       Impact factor: 9.308

3.  Policy issues for expanding newborn screening programs: the cystic fibrosis newborn screening experience in the United States.

Authors:  Benjamin S Wilfond; Sarah E Gollust
Journal:  J Pediatr       Date:  2005-05       Impact factor: 4.406
  3 in total
  1 in total

Review 1.  Newborn screening for cystic fibrosis: a lesson in public health disparities.

Authors:  Lainie Friedman Ross
Journal:  J Pediatr       Date:  2008-09       Impact factor: 4.406
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.